These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 28900840)
1. Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder. Grabbert M; Grimm T; Buchner A; Kretschmer A; Apfelbeck M; Schulz G; Jokisch F; Schneevoigt BS; Stief CG; Karl A Int Urol Nephrol; 2017 Dec; 49(12):2137-2142. PubMed ID: 28900840 [TBL] [Abstract][Full Text] [Related]
2. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy. Abdi H; Pourmalek F; Gleave ME; So AI; Black PC World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208 [TBL] [Abstract][Full Text] [Related]
3. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269 [TBL] [Abstract][Full Text] [Related]
4. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. Evers PD; Logan JE; Sills V; Chin AI World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991 [TBL] [Abstract][Full Text] [Related]
5. Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients. Mistretta FA; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI Cancer Epidemiol; 2019 Apr; 59():135-142. PubMed ID: 30771698 [TBL] [Abstract][Full Text] [Related]
6. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849 [TBL] [Abstract][Full Text] [Related]
7. Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study. Yuan JB; Zu XB; Miao JG; Wang J; Chen MF; Qi L BJU Int; 2013 Jul; 112(2):E87-91. PubMed ID: 23323729 [TBL] [Abstract][Full Text] [Related]
8. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182 [TBL] [Abstract][Full Text] [Related]
9. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. May M; Herrmann E; Bolenz C; Brookman-May S; Tiemann A; Moritz R; Fritsche HM; Burger M; Trojan L; Michel MS; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Bastian PJ Ann Surg Oncol; 2011 Jul; 18(7):2018-25. PubMed ID: 21246405 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer. Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816 [TBL] [Abstract][Full Text] [Related]
11. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma. Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240 [TBL] [Abstract][Full Text] [Related]
12. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844 [TBL] [Abstract][Full Text] [Related]
13. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients. Kim HS; Kwak C; Kim HH; Ku JH Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845 [TBL] [Abstract][Full Text] [Related]
14. Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer. Moschini M; Afferi L; Gandaglia G; D'Andrea D; Zamboni S; Di Bona C; Mordasini L; Mattei A; Baumeister P; Martini A; Burgio G; Shariat SF; Sanchez-Salas R; Cathelineau X; Stabile A; Zaffuto E; Salonia A; Colombo R; Necchi A; Montorsi F; Briganti A; Gallina A Eur Urol Focus; 2021 Sep; 7(5):1067-1074. PubMed ID: 33020030 [TBL] [Abstract][Full Text] [Related]
15. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer. Sodagum L; Passarelli R; Pfail J; Patel HV; Chua K; Doppalapudi SK; Golombos D; Elsamra SE; Singer EA; Jang TL; Srivastava A; Ghodoussipour S Urol Oncol; 2024 Jan; 42(1):21.e9-21.e20. PubMed ID: 37953186 [TBL] [Abstract][Full Text] [Related]
16. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169 [TBL] [Abstract][Full Text] [Related]
17. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up. Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587 [TBL] [Abstract][Full Text] [Related]
18. Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis. Xu K; Lang B; Fu B; Shi T; Wang B; Zhang X J Endourol; 2017 Dec; 31(12):1259-1268. PubMed ID: 28967303 [TBL] [Abstract][Full Text] [Related]
19. Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution. Tamalunas A; Volz Y; Schlenker BA; Buchner A; Kretschmer A; Jokisch F; Rodler S; Schulz G; Eismann L; Pfitzinger P; Stief CG; Grimm T Urol Int; 2020; 104(11-12):975-981. PubMed ID: 32871580 [TBL] [Abstract][Full Text] [Related]
20. Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results. Ma B; Li Y; Han S; Jiang X; Zhao Y; Guo J; Quan C; Niu Y Eur J Surg Oncol; 2019 Oct; 45(10):1993-1999. PubMed ID: 31327502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]